Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 8, 2021 - The drug shortage of bupivacaine/epinephrine injection products is ongoing. These products have been unavailable for at least 90 days.
Return to publications